Biomarker Testing in NSCLC: Who, What, When?
Guest: Rasheda Persinger MSN, AGNP-C, AOCNP
\n\n Guest: Terran Sims, MSN, ACNP-C, CNN, COCN-C
\n\n\n \n
In this activity, learn about the most recent recommendations for biomarker/molecular testing and personalized treatment plans for patients with non-small-cell lung cancer (NSCLC) based on results from testing.